Drug Pricing Reform Gathers Steam (Part 2)
FDA Law
SEPTEMBER 14, 2021
PART 1: MAXIMUM FAIR PRICE PAYMENT LIMITATION UNDER MEDICARE PARTS B AND D AND THE COMMERCIAL INSURANCE MARKET. The MFP would be established through negotiations between HHS and the manufacturer and would incorporate foreign pricing benchmarks, as further described below. the amount Part D plans pay pharmacies for the drugs).
52 
Let's personalize your content